Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting

Current Medical Research and Opinion

Volumn 25, Issue 6, 2009, Pages 1319-1328

  Ritzwoller, Debra P ^a   Ellis, Jennifer L ^a   Korner, Eli J ^b   Hartsfield, Cynthia L ^c   Sadosky, Alesia ^d  

^a KAISER PERMANENTE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c Abbott Global Pharmaceutical Research and Development   (United States)

^d PFIZER INC   (United States)

Author keywords

Burden; Comorbidities; Costs; Diabetic peripheral neuropathy; Economics; Healthcare utilization

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INFECTION; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PERIPHERAL NEUROPATHY; PREVALENCE; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEUROPATHIES; DIAGNOSIS-RELATED GROUPS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PAIN; PATIENT ADMISSION; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67649445910     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902864749     Document Type: Article

References (33)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917-932
2. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824 (Pubitemid 23121981)
3. Martyn CN, Hughes RAC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-318 (Pubitemid 27199100)
4. Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev 1999;7:245-252 (Pubitemid 30072308)
5. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004;27:1591-1597
6. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-982 (Pubitemid 39215316)
7. Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-1522 (Pubitemid 44127574)
8. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143-149 (Pubitemid 38879392)
9. Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care 2003;26:1790-1795 (Pubitemid 36929121)
10. Gore M, Brandenburg N, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-385 (Pubitemid 41527124)
11. Stewart WF, Ricci JA, Chee E, et al. Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce. J Occup Environ Med 2007;49:672-679 (Pubitemid 46918860)
12. Daousi C, Benbow SJ, Woodward A, et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006;23:1021-1024 (Pubitemid 44257948)
13. Boulton AJM, Knight G, Drury J, et al. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 1985;8:125-128 (Pubitemid 15044008)
14. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94
15. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;19:2-8 (Pubitemid 36285366)
16. Backonja M, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 1998;16:776-789 (Pubitemid 28509787)
17. Duby JJ, Campbell RK, Setter SM, et al. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61 (Pubitemid 39004640)
18. Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-1486 (Pubitemid 38680000)
19. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990;13:513-521
20. Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007;8(Suppl 2):S50-62. Review (Pubitemid 47288511)
21. Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997;20:1396-1402 (Pubitemid 27366814)
22. O'Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 1998;21:1122-1128 (Pubitemid 28368519)
23. Brandle M, Zhou H, Smith BRK, et al. The direct costs of type 2 diabetes. Diabetes Care 2003;26:2300-2304
24. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159:1873-1880 (Pubitemid 29424707)
25. Mody R, Kalsekar I, Kavookjian J, et al. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. J Diabetes Complications 2007;21:75-83 (Pubitemid 46304268)
26. Hartsfield CL, Korner EJ, Ellis JL, et al. Painful diabetic peripheral neuropathy in a managed care setting: patient identification, prevalence estimates, and pharmacy utilization patterns. Popul Health Manag 2008;11:317-328
27. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-1139 (Pubitemid 41587600)
28. Ritzwoller DP, Crounse L, Shetterly S, et al. The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord 2006;7:72 (Pubitemid 44496278)
29. von Korff M, Deyo RA, Cherkin D, et al. Back pain in primary care. Outcomes at 1 year. Spine 1993;18:855-862
30. Cherkin DC, Deyo RA, Volinn E, et al. Use of the International Classification of Diseases (ICD-9-CM) to identify hospitalizations for mechanical low back problems in administrative databases. Spine 1992;17:817-825
31. Fishman PA, Stang PE, Hogue SL. Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. J Clin Psychiatry 2007;68:248-253 (Pubitemid 46362646)
32. Harvey EC. Estimating regression models with multiplicative heteroscedasticity. Econometrica 1976;44:461-465
33. Pagano E, Bo S, Petrinco M, et al. Factors affecting hospitalization costs in type 2 diabetic patients. J Diabetes Complications 2009;23(1):1-6